The AstraZeneca Competition Case: Patent Strategies Constituting Abuse of Dominance
On 6 December 2012, the Court of Justice of the European Union affirmed that AstraZeneca abused its dominant position by engaging in certain intellectual property strategies aimed at protecting its...Read more